JP2018531984A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018531984A5 JP2018531984A5 JP2018522570A JP2018522570A JP2018531984A5 JP 2018531984 A5 JP2018531984 A5 JP 2018531984A5 JP 2018522570 A JP2018522570 A JP 2018522570A JP 2018522570 A JP2018522570 A JP 2018522570A JP 2018531984 A5 JP2018531984 A5 JP 2018531984A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- botulinum toxin
- component
- positively charged
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021162802A JP2022008814A (ja) | 2015-10-29 | 2021-10-01 | 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562248255P | 2015-10-29 | 2015-10-29 | |
| US62/248,255 | 2015-10-29 | ||
| PCT/US2016/059492 WO2017075468A1 (en) | 2015-10-29 | 2016-10-28 | Injectable botulinum toxin formulations and methods of use thereof having long duration of therapeutic or cosmetic effect |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021162802A Division JP2022008814A (ja) | 2015-10-29 | 2021-10-01 | 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018531984A JP2018531984A (ja) | 2018-11-01 |
| JP2018531984A5 true JP2018531984A5 (enExample) | 2019-12-12 |
| JP6955491B2 JP6955491B2 (ja) | 2021-10-27 |
Family
ID=58630886
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018522570A Active JP6955491B2 (ja) | 2015-10-29 | 2016-10-28 | 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法 |
| JP2021162802A Pending JP2022008814A (ja) | 2015-10-29 | 2021-10-01 | 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021162802A Pending JP2022008814A (ja) | 2015-10-29 | 2021-10-01 | 治療効果又は美容効果の長い持続時間を有する、注射用ボツリヌス毒素製剤及びこれらの使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20180311333A1 (enExample) |
| EP (1) | EP3368071B2 (enExample) |
| JP (2) | JP6955491B2 (enExample) |
| KR (1) | KR102794108B1 (enExample) |
| CN (1) | CN109069608A (enExample) |
| AU (2) | AU2016343748A1 (enExample) |
| CA (1) | CA3003447A1 (enExample) |
| CO (1) | CO2018005361A2 (enExample) |
| DK (1) | DK3368071T3 (enExample) |
| ES (1) | ES2907652T3 (enExample) |
| IL (2) | IL259016A (enExample) |
| MX (1) | MX2018005256A (enExample) |
| RU (1) | RU2018119765A (enExample) |
| SG (2) | SG11201803566TA (enExample) |
| WO (1) | WO2017075468A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070110402A (ko) * | 2005-03-03 | 2007-11-16 | 레반스 테라퓨틱스 | 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법 |
| CN102869373B (zh) | 2009-06-25 | 2017-05-10 | 雷文斯治疗公司 | 不含白蛋白的肉毒杆菌毒素制剂 |
| US20120196349A1 (en) * | 2009-10-21 | 2012-08-02 | Revance Therapeutics, Inc. | Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin |
| CN109069608A (zh) | 2015-10-29 | 2018-12-21 | 雷文斯治疗公司 | 具有长的治疗或美容效应持续时间的可注射肉毒杆菌毒素制剂以及其使用方法 |
| EP3541358A1 (en) | 2016-11-21 | 2019-09-25 | Eirion Therapeutics, Inc. | Transdermal delivery of large agents |
| CA3057302A1 (en) * | 2017-03-22 | 2018-09-27 | Bonti, Inc. | Botulinum neurotoxin serotype e for use in cosmetic treatment |
| AU2018270092C1 (en) | 2017-05-18 | 2026-01-08 | Revance Therapeutics, Inc. | Methods of treatment for cervical dystonia |
| US11400136B2 (en) | 2017-06-19 | 2022-08-02 | President And Fellows Of Harvard College | Methods and compositions for treating a microbial infection |
| EP3675900A4 (en) | 2017-08-28 | 2021-05-05 | Revance Therapeutics, Inc. | Transmucosal botulinum toxin compositions, kits, and methods for treating bladder disorders |
| US20200390871A1 (en) * | 2017-11-03 | 2020-12-17 | Revance Therapeutics, Inc. | Botulinum toxin formulations and methods of use thereof in plantar fascitis with extended duration of effect |
| RU2020121540A (ru) * | 2017-12-04 | 2022-01-10 | Реванс Терапьютикс, Инк. | Инъецируемые составы ботулинического токсина и способы их применения с высокими показателями ответа и длительной продолжительностью эффекта |
| WO2020056191A1 (en) | 2018-09-13 | 2020-03-19 | Eirion Therapeutics, Inc. | Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors |
| CN112955166A (zh) * | 2018-09-13 | 2021-06-11 | 阿勒根公司 | 治疗咬肌肥大的方法 |
| CN114173808A (zh) * | 2019-05-14 | 2022-03-11 | 艾里奥治疗公司 | 延迟峰值效应和/或延长反应持续时间 |
| AU2021240083A1 (en) * | 2020-03-18 | 2022-10-20 | Revance Therapeutics, Inc. | Injectable botulinum toxin methods for treating headaches |
| KR102397708B1 (ko) * | 2020-04-29 | 2022-05-16 | 한국화학연구원 | 탄닌산을 포함하는 보툴리눔 독소 약제학적 조성물 |
| KR102324855B1 (ko) * | 2020-05-20 | 2021-11-11 | 오스템임플란트 주식회사 | 보툴리눔 독소를 포함하는 약제학적 액상 조성물 |
| KR20230086752A (ko) * | 2020-10-13 | 2023-06-15 | 레반스 테라퓨틱스, 아이엔씨. | 경부 근긴장이상증의 치료 방법 |
| KR102266384B1 (ko) * | 2021-01-25 | 2021-06-21 | 주식회사 울트라브이 | 필러용 생분해성 고분자 미세입자, 이를 포함한 필러용 동결건조체, 그 제조방법 및 상기 동결건조체를 포함하는 필러용 주사제 |
| CA3209156A1 (en) * | 2021-02-21 | 2022-08-25 | Revance Therapeutics, Inc. | Methods of and compositions for treatment of upper limb spasticity |
| US20240216487A1 (en) * | 2021-04-26 | 2024-07-04 | Shanghaitech University | Intramuscular compositions of botulinum neurotoxins |
| US20250018016A1 (en) * | 2021-11-15 | 2025-01-16 | Medytox Inc. | Botulinum neurotoxin composition |
| WO2023239229A1 (ko) * | 2022-06-10 | 2023-12-14 | (주)메디톡스 | 보툴리눔 독소 안정화 조성물, 이를 포함하는 보툴리눔 독소 제제 및 이에 사용하기 위한 폴리펩티드 |
| KR102714765B1 (ko) * | 2023-05-04 | 2024-10-11 | 주식회사 파마리서치바이오 | Dna 단편 혼합물 및 보툴리눔 독소를 포함하는 보툴리눔 독소의 생체 내 지속성이 증가된 지속성 제제 |
| CN122514358A (zh) * | 2023-09-19 | 2026-08-04 | 雷文斯治疗公司 | 需要快速起效美容效果和更平滑皮肤外观的患者中的使用肉毒毒素的治疗 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5877278A (en) | 1992-09-24 | 1999-03-02 | Chiron Corporation | Synthesis of N-substituted oligomers |
| US6444209B1 (en) | 1996-10-28 | 2002-09-03 | Wisconsin Alumni Research Foundation | Hybrid botulinal neurotoxins |
| ES2237551T3 (es) | 2000-02-08 | 2005-08-01 | Allergan, Inc. | Composiciones farmaceuticas que contienen toxina botulinica. |
| DE10043982A1 (de) * | 2000-09-05 | 2002-03-14 | Armin Maurer | Verfahren zur Verbesserung des Haarwuchses menschlichen Kopfhaares |
| GB2416122A (en) | 2004-07-12 | 2006-01-18 | Ipsen Ltd | Botulinum neurotoxin composition |
| LT2379104T (lt) | 2008-12-31 | 2018-04-10 | Revance Therapeutics, Inc. | Injekcinės botulino toksino vaisto formos |
| CN102869373B (zh) | 2009-06-25 | 2017-05-10 | 雷文斯治疗公司 | 不含白蛋白的肉毒杆菌毒素制剂 |
| ES3036435T3 (en) * | 2011-01-07 | 2025-09-18 | Revance Therapeutics Inc | Kits for topical application, removal, and inactivation of therapeutic or cosmetic botulinum toxin compositions |
| US20130251770A1 (en) | 2012-03-22 | 2013-09-26 | Revance Therapeutics, Inc. | Method of Treatment of Wrinkles Using Topical Chemodenervating Agents |
| WO2014066916A2 (en) * | 2012-10-28 | 2014-05-01 | Revance Therapeutics, Inc. | Compositions and methods for safe treatment of rhinitis |
| CN109069608A (zh) | 2015-10-29 | 2018-12-21 | 雷文斯治疗公司 | 具有长的治疗或美容效应持续时间的可注射肉毒杆菌毒素制剂以及其使用方法 |
-
2016
- 2016-10-28 CN CN201680072956.XA patent/CN109069608A/zh active Pending
- 2016-10-28 SG SG11201803566TA patent/SG11201803566TA/en unknown
- 2016-10-28 DK DK16860952.7T patent/DK3368071T3/da active
- 2016-10-28 ES ES16860952T patent/ES2907652T3/es active Active
- 2016-10-28 CA CA3003447A patent/CA3003447A1/en active Pending
- 2016-10-28 SG SG10202004337WA patent/SG10202004337WA/en unknown
- 2016-10-28 MX MX2018005256A patent/MX2018005256A/es unknown
- 2016-10-28 EP EP16860952.7A patent/EP3368071B2/en active Active
- 2016-10-28 RU RU2018119765A patent/RU2018119765A/ru not_active Application Discontinuation
- 2016-10-28 US US15/771,635 patent/US20180311333A1/en not_active Abandoned
- 2016-10-28 AU AU2016343748A patent/AU2016343748A1/en not_active Abandoned
- 2016-10-28 KR KR1020187014681A patent/KR102794108B1/ko active Active
- 2016-10-28 WO PCT/US2016/059492 patent/WO2017075468A1/en not_active Ceased
- 2016-10-28 JP JP2018522570A patent/JP6955491B2/ja active Active
-
2018
- 2018-04-29 IL IL259016A patent/IL259016A/en unknown
- 2018-05-23 CO CONC2018/0005361A patent/CO2018005361A2/es unknown
-
2021
- 2021-09-10 US US17/472,525 patent/US20220062400A1/en active Pending
- 2021-09-19 IL IL286472A patent/IL286472A/en unknown
- 2021-10-01 JP JP2021162802A patent/JP2022008814A/ja active Pending
-
2023
- 2023-10-06 AU AU2023241373A patent/AU2023241373A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018119765A (ru) | Инъекционные препараты на основе ботулотоксина и способы их применения, обеспечивающие длительное терапевтическое и косметического действие | |
| JP2016540785A5 (enExample) | ||
| FI3506886T3 (fi) | Erittäin väkevöityjä alhaisen viskositeetin masp-2:ta estäviä vasta-aineformulaatioita, tarvikesarjoja ja menetelmiä | |
| HRP20241127T1 (hr) | Formulacije i doze pegilirane urikaze | |
| JP2015517488A5 (enExample) | ||
| WO2013164789A3 (en) | Lyophilised and aqueous anti-cd40 antibody formulations | |
| JP2015231997A5 (enExample) | ||
| WO2009046824A3 (en) | Use of apelin-12 as a therapeutic agent, eg for treating excessive angiogenesis | |
| HRP20251088T1 (hr) | Upotreba dugodjelujućih peptida glp‑1 | |
| JP2018505882A5 (enExample) | ||
| WO2009033668A3 (en) | Use of a peptide as a therapeutic agent | |
| WO2009040068A3 (en) | Use of a peptide as a therapeutic agent | |
| JP2013543505A5 (enExample) | ||
| WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
| WO2009033768A3 (en) | Use of a peptide as a therapeutic agent | |
| JP2015134763A5 (enExample) | ||
| JP2016539921A5 (enExample) | ||
| WO2009033755A3 (en) | Use of l-carnosine as a therapeutic agent | |
| WO2009033712A3 (en) | Use of melanotan ii as a therapeutic agent | |
| IL307992A (en) | Parasitic formulations containing isoxazoline and methods for treating blepharitis | |
| HRP20230300T1 (hr) | Kombinacije imetelstata i venetoklaksa za liječenje akutne mijeloidne leukemije | |
| JP2013532729A5 (enExample) | ||
| JP2015520196A5 (enExample) | ||
| JP2017512194A5 (enExample) | ||
| HRP20181021T1 (hr) | Formulacija za bispecifične aktivatore limfocita t (bites) |